(Press-News.org) Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and their collaborators have developed an experimental, nanoparticle-based vaccine against Epstein-Barr virus (EBV) that can induce potent neutralizing antibodies in vaccinated mice and nonhuman primates. Microscopic particles, known as nanoparticles, are being investigated as potential delivery vehicles for vaccines. The scientists' findings suggest that using a structure-based vaccine design and self-assembling nanoparticles to deliver a viral protein that prompts an immune response could be a promising approach for developing an EBV vaccine for humans.
First identified in 1964, EBV is one of the most common human viruses in the world, infecting nine out of 10 people at some point in their lives. Most people experience no illness or only mild symptoms. Most commonly spread through saliva, it is best known as the major cause of infectious mononucleosis, or mono. Worldwide, EBV is also associated with nearly 200,000 annual cases of cancer, including Burkitt and Hodgkin lymphoma, non-Hodgkin lymphoma, and stomach and nasopharyngeal cancers. Currently, there is no licensed vaccine to prevent EBV infection.
Most efforts to develop a preventive EBV vaccine have focused on glycoprotein 350, or gp350, a molecule on the surface of EBV that helps the virus attach to certain immune system cells called B cells. EBV gp350 is thought to be a key target for antibodies capable of preventing virus infection. Previously, scientists showed that vaccinating monkeys with gp350 protected the animals from developing lymphomas after exposure to a high dose of EBV. However, in the only large human clinical trial of an experimental EBV vaccine conducted to date, the EBV gp350 vaccine did not prevent EBV infection, but did reduce the rate of infectious mononucleosis by 78 percent.
To build on these findings, the researchers designed a nanoparticle-based vaccine that expressed the cell-binding portion of gp350. In their testing, the experimental vaccine induced potent neutralizing antibodies in both mice and nonhuman primates. Further, the investigational vaccine induced up to 100-fold higher levels of neutralizing antibodies in mice compared with previous vaccine designs by using structure-based design to precisely target the cell-binding site on gp350, the vulnerable part of the virus. The researchers believe the nanoparticle vaccine design could be used to create or redesign vaccines against other pathogens for which it has been difficult to induce effective immunity.
INFORMATION:
ARTICLE:
M Kanekiyo et al. Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor Binding Site. Cell DOI: 10.1016/j.cell.2015.07.043 (2015).
WHO:
NIAID director Anthony S. Fauci, M.D., and Jeffrey Cohen, M.D., chief of NIAID's Laboratory of Infectious Diseases and co-corresponding author on the study, are available to comment.
CONTACT:
To schedule interviews, please contact Emily Mullin, (301) 402-1663, emily.mullin@nih.gov.
NIAID conducts and supports research--at NIH, throughout the United States, and worldwide--to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
NIH...Turning Discovery Into Health END
In a recent study, restricting dietary fat led to body fat loss at a rate 68 percent higher than cutting the same number of carbohydrate calories when adults with obesity ate strictly controlled diets. Carb restriction lowered production of the fat-regulating hormone insulin and increased fat burning as expected, whereas fat restriction had no observed changes in insulin production or fat burning. The research was conducted at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. Results were published ...
Engineers from the University of Sheffield have developed a novel technique to predict when bearings inside wind turbines will fail which could make wind energy cheaper.
The method, published in the journal Proceedings of the Royal Society A and developed by Mechanical Engineering research student Wenqu Chen, uses ultrasonic waves to measure the load transmitted through a ball bearing in a wind turbine. The stress on wind turbine is recorded and then engineers can forecast its remaining service life.
When a bearing is subject to a load, its thickness is reduced by ...
Black-footed ferrets, a critically endangered species native to North America, have renewed hope for future survival thanks to successful efforts by a coalition of conservationists, including scientists at Lincoln Park Zoo, to reproduce genetically important offspring using frozen semen from a ferret who has been dead for approximately 20 years. The sire, "Scarface," as he is affectionately called by the team, was one of the last 18 black-footed ferrets to exist in the world in the 1980s. Eight kits, including offspring of Scarface, were born recently, significantly increasing ...
One of the more heartbreaking realities of Alzheimer's is the moment when a loved one struggling with the disease no longer fully recognizes a family member or close friend who is caring for them.
Now, new research from Washington University in St. Louis has identified a novel learning and memory brain network that processes incoming information based on whether it's something we've experienced previously or is deemed to be altogether new and unknown, helping us recognize, for instance, whether the face before us is that of a familiar friend or a complete stranger.
Forthcoming ...
Multigene testing of women negative for BRCA1 and BRCA2 found some of them harbored other harmful genetic mutations, most commonly moderate-risk breast and ovarian cancer genes and Lynch syndrome genes, which increase ovarian cancer risk, according to an article published online by JAMA Oncology.
Multigene panel genetic tests are increasingly recommended for patients evaluated for a predisposition to hereditary breast/ovarian cancer (HBOC). However, the rapid introduction of these tests has raised concerns because many of the tested genes are low- to moderate-risk genes ...
A study by researchers at three academic medical centers has shown that screening women with a suspected risk of hereditary breast or ovarian cancer for risk-associated genes other than BRCA1 and 2 provides information that can change clinical recommendations for patients and their family members. The report from a team led by a Massachusetts General Hospital (MGH) Cancer Center investigator is being published in the August issue of JAMA Oncology.
"The traditional approach has been to test most women with suspected hereditary risk for breast and/or ovarian cancer for ...
A University of Manchester study which followed up 38,415 people admitted to hospital with self-harm has, for the first time, investigated the association between the treatment patients receive in hospital and their subsequent risk of death.
Published in the Lancet Psychiatry, the study looked at adults who had self-harmed and attended five hospital emergency departments in Manchester, Oxford and Derby between 2000 and 2010. The researchers found that within 12 months, 261 had died by suicide and a further 832 had died from other causes.
The study also examined the ...
Organ transplant recipients are twice as likely to develop melanoma as people who do not undergo a transplant, and three times more likely to die of the dangerous skin cancer, suggests new research led by a Johns Hopkins Bloomberg School of Public Health student.
The findings, reported Aug. 13 in the Journal of Investigative Dermatology, suggest that the immunosuppressive medications that transplant recipients receive to keep them from rejecting their new organs -- especially the high doses administered at the time of transplant -- may make them more susceptible to later ...
A study on granting local sales people pricing discretion shows that profits improve by up to 11% when local sales forces are empowered to negotiate with customers. However a centralized system that uses optimization techniques and limits local sales discretion improves profits still further, by an additional 20%. The research appears in the current issue of Management Science, a publication of the Institute for Operations Research and the Management Sciences (INFORMS), the leading professional association in analytics and operations research.
"This hybrid approach balances ...
Summary: Children born with the major congenital heart defect hypoplastic left heart syndrome (HLHS) often must undergo a series of corrective surgeries beginning at birth. While most have the standard three-stage Norwood procedure, a hybrid strategy has been introduced to offset some disadvantages associated with the Norwood surgeries. In a report in The Journal of Thoracic and Cardiovascular Surgery, investigators compare whether outcomes can be improved if an arterial shunt is used as a source of pulmonary blood flow rather than the more conventional venous shunt as ...
